Benidipine Hydrochloride Tablets (Sainiping) 8mg – For Laboratory Research Use Only

$2.00

Benidipine Hydrochloride Tablets (Sainiping) deliver 8mg per tablet. Supplied as 14 tablets per box. NMPA-approved for research use only. Wholesale and retail supported.?For wholesale prices, other specifications and uses, please consult our staff?

Compare

描述

Benidipine hydrochloride is a dihydropyridine calcium channel blocker studied for its effects on cardiovascular conditions, particularly hypertension and angina. It acts on L-, N-, and T-type calcium channels, providing prolonged vasodilation in preclinical research models.

Each Sainiping tablet contains 8mg of benidipine hydrochloride, supplied in a box of 14 tablets (7 tablets × 2 blisters). The product is manufactured by Chongqing Shenghuaxi Pharmaceutical Co., Ltd., approved by the NMPA under number H20244790, and identified by product code 86909568000418.

?? For laboratory research use only. Not for human or veterinary use.

Contents hide

1 Product Specifications

2 Mechanism & Research Applications

3 Safety & Handling

4 Research Use Disclaimer

Product Specifications

Parameter	Details
Product Name	Benidipine Hydrochloride Tablets (Sainiping)
Active Ingredient	Benidipine Hydrochloride
CAS Number	105979-17-7
Molecular Formula	C28H31N3O6·HCl
Molecular Weight	541.02 g/mol (as hydrochloride salt)
Strength	8mg per tablet
Dosage Form	Tablet
Quantity	14 tablets per box (7 tablets × 2 blister packs)
Approval Number	H20244790 (China NMPA)
Product Code	86909568000418
Manufacturer	Chongqing Shenghuaxi Pharmaceutical Co., Ltd.
Barcode	6933982501095
Storage Conditions	Store in a cool, dry place below 25°C. Avoid direct sunlight.
Intended Use	Laboratory research only

Mechanism & Research Applications

Benidipine blocks multiple calcium channels (L-, N-, and T-type), resulting in long-lasting vasodilation and reduced peripheral vascular resistance. It is of particular interest in:

Hypertension models
Angina and ischemia studies
Renal protection research
Multichannel calcium inhibition pharmacology

Researchers utilize it to evaluate novel antihypertensive strategies and cardiovascular safety profiling.

Safety & Handling

Intended Use: For laboratory research only. Not for clinical, diagnostic, or veterinary use.
Handling: Use protective gloves, eyewear, and lab coat when handling.
Storage: Store sealed below 25°C, in a dry place away from light.
Disposal: Follow local hazardous chemical waste disposal regulations.

Research Use Disclaimer

This product is designated for laboratory research only. It is not approved for human or animal use. Any misuse may lead to regulatory consequences or health risks. Handle responsibly and in compliance with all institutional safety standards.

其他信息

重量	1 公斤
尺寸	26 × 23 × 26 厘米

评价

目前还没有评价

成为第一个“Benidipine Hydrochloride Tablets (Sainiping) 8mg – For Laboratory Research Use Only” 的评价者

Q1: Is this product intended for medical treatment?

A1: No. This product is for laboratory research use only, not for human or veterinary applications.

Q2: Can I order in bulk for institutional research?

A2: Yes, both wholesale and retail quantities are supported. Contact us for volume pricing.

Q3: Are COA and SDS documents available?

A3: Yes, both Certificate of Analysis and Safety Data Sheet are available upon request.

Q4: What research applications is benidipine suited for?

A4: It is commonly used in studies on hypertension, cardiac function, renal effects, and calcium channel pharmacology.

Q5: How is this product packaged?

A5: It comes in a box containing 2 blister packs of 7 tablets each (14 tablets total).

Q6: How does benidipine compare to other calcium channel blockers in research?

A6: Benidipine’s triple-channel blockade (L-, N-, and T-type) offers a unique model for studying long-acting vasodilation compared to single-channel agents like amlodipine.

Q7: What is the typical onset and duration of benidipine in lab models?

A7: In research settings, benidipine exhibits a slower onset but prolonged duration, ideal for sustained-release hypertension modeling.

Q8: Can benidipine be combined with ACE inhibitors in studies?

A8: Yes, it is often used in combinatory research for dual-pathway antihypertensive investigations.

Q9: Is benidipine effective in renal protection models?

A9: Studies suggest potential nephroprotective effects, making it valuable in chronic kidney disease (CKD) research.

Q10: Are there animal model studies using benidipine hydrochloride?

A10: Yes, it has been widely used in rodent and canine models to study cardiovascular and renal physiology.

Benidipine Hydrochloride Tablets (Sainiping) 8mg – For Laboratory Research Use Only

Benidipine Hydrochloride Tablets (Sainiping) 8mg – For Laboratory Research Use Only